Search by Drug Name or NDC

    NDC 70010-0784-09 Bupropion hydrochloride 150 mg/1 Details

    Bupropion hydrochloride 150 mg/1

    Bupropion hydrochloride is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Granules Pharmaceuticals Inc.. The primary component is BUPROPION HYDROCHLORIDE.

    Product Information

    NDC 70010-0784
    Product ID 70010-784_0bfdb8c7-f993-4161-e063-6294a90aa7b3
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Bupropion hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Bupropion hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 150
    Active Ingredient Units mg/1
    Substance Name BUPROPION HYDROCHLORIDE
    Labeler Name Granules Pharmaceuticals Inc.
    Pharmaceutical Class Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA215568
    Listing Certified Through 2025-12-31

    Package

    NDC 70010-0784-09 (70010078409)

    NDC Package Code 70010-784-09
    Billing NDC 70010078409
    Package 90 TABLET in 1 BOTTLE (70010-784-09)
    Marketing Start Date 2022-12-15
    NDC Exclude Flag N
    Pricing Information N/A